Status:
COMPLETED
Clinical Study Comparing Submerged Versus Trans-mucosal Healing of P.004 Implants in the Anterior Mandible and Maxilla
Lead Sponsor:
Institut Straumann AG
Conditions:
Jaw, Edentulous, Partially
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is To demonstrate that there is no difference in change in bone level around P.004 implants between 1st stage surgery and 6 months post surgery when transmucosal implant plac...
Detailed Description
The primary objective of this study is to determine the level at which the bone can be maintained in relation to the implant shoulder for the P.004 two-stage implant when placed in a submerged or a tr...
Eligibility Criteria
Inclusion
- Males and females \>18 years of age.
- Implant placement planned in the anterior maxilla or mandible (FDI tooth numbers 21 - 25, 11 - 15, 31-35, 41-45).
- Tooth site must have a natural tooth both mesially and distally in the adjacent tooth positions
- Opposing dentition of natural teeth, or tooth or implant-supported fixed restorations.
- Adequate bone quality and quantity at the implant site to permit the insertion of a Straumann P.004 SLActive implant of 8, 10, 12, or 14 mm length.
- Presence of a sufficient band of keratinized mucosa (min. 2 mm) to allow surgical manipulation and suturing according to the protocol
- Signed informed consent document before being treated in the study
Exclusion
- Systemic disease that would interfere with dental implant therapy (e.g. uncontrolled diabetes)
- Any contraindications for oral surgical procedures
- Current untreated periodontitis or gingivitis
- Probing pocket depth of more than 4 mm at one of the adjacent teeth
- Mucosal diseases (e.g. erosive lichen planus)
- History of local irradiation therapy
- Bone augmentation procedures if the procedure require healing time of more than 12 weeks after implant placement
- Implants in adjacent position to planned implant
- Severe bruxing or clenching habits
- Heavy smokers: Patients who smoke more than 20 cigarettes per day
- Conditions or circumstances, in the opinion of the investigator, which would prevent completion of study participation.
- Patients with inadequate oral hygiene or unmotivated for adequate home care
- Secondary Exclusion Criteria at Implant Surgery:
- Lack of primary stability of the implant
- Inappropriate implant position to insert implants according to the prosthetic requirements.
- Patients with augmentation procedures requiring more than 12 weeks healing time.
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
145 Patients enrolled
Trial Details
Trial ID
NCT00906425
Start Date
October 1 2006
End Date
October 1 2013
Last Update
March 30 2016
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Jeffery Ganeles
Boca Raton, Florida, United States, 33431
2
Dr. William C. Martin
Gainesville, Florida, United States, 32610
3
Dr. Stephen T. Chen
Melbourne, Australia, 3123
4
Prof. Wiltfang
Kiel, Schleswig-Holstein, Germany, 24105